NCT06696586 is a Phase 4 clinical trial of Fentanyl infusion in Bier Block, sponsored by Assiut University.

Who is sponsoring NCT06696586?

NCT06696586 is sponsored by Assiut University.

What drugs are being tested in NCT06696586?

Interventions in NCT06696586: Fentanyl infusion, Fentanyl Injection.

What condition does NCT06696586 study?

NCT06696586 studies Bier Block, Hand Surgery.

Is NCT06696586 still recruiting?

NCT06696586 is currently not yet recruiting. Last updated 18 April 2025.

Last reviewed 2025-04-18 · How we verify

NCT06696586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Effect of Systemic Fentanyl Infusion and Fentanyl Added as An Adjuvant to Lidocaine in Bier Block For Controlling Pain in Patients Undergoing Hand Surgeries

Not yet recruiting Phase 4 Last updated 18 April 2025

What this trial tests

Phase 4 trial testing Fentanyl infusion in Bier Block in 84 participants. Not yet recruiting.

Timeline

1 July 2025

Primary endpoint
1 December 2026

1 January 2027

Quick facts

Lead sponsor	Assiut University
Phase	Phase 4
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	84
Start date	1 July 2025
Primary completion	1 December 2026
Estimated completion	1 January 2027

Drugs / interventions tested

Fentanyl infusion — full drug profile →
Fentanyl Injection

Conditions studied

Bier Block — all drugs for Bier Block →
Hand Surgery — all drugs for Hand Surgery →

Sponsor

Assiut University

Who can join

Adults 18 to 40, any sex, with Bier Block or Hand Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Injury and deformity of the upper extremity can result in dysfunction to nerves, tendons and bones which can lead to disability and pain. Various techniques of regional anesthesia are frequently used for upper extremity surgery. Specifically, intravenous regional anesthesia, the Bier block, is an effective anesthetic technique. This technique, developed by Dr August Bier in 1908, provides complete anesthesia, a bloodless field, and eliminates the need for general anesthesia. However, it was not until the 1960s that this technique was reintroduced and used in upper extremity surgery due to several disadvantages and reports of major complications. Because of the dose of lidocaine and tourniquet time, there is potential for cardiac and neurological complications such as arrhythmias, seizures, and compartment syndrome the aim of this study To evaluate the effect of Systemic Fentanyl Infusion compared to addition of Fentanyl as An Adjuvant to Lidocaine in Bier Block for Controlling Pain in Patients Undergoing Hand Surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fentanyl infusion

Trials testing the same drug.

NCT07350668 — Opioid-Free vs Opioid-Based Anesthesia for Nasal Surgeries · Phase 3 · completed
NCT06650371 — Opioid Free Anesthesia Versus Opioid Based Anesthesia · NA · not yet recruiting
NCT05691920 — Regional Blocks for CABG Artery Bypass Graft Surgery · Phase 3 · unknown

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06696586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 18 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06696586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing